Sign In
Buy VIR
$8.77
+0.0300 (+0.343%)
At Close: Jun 03, 2026
VIR Stock Price Increases Over 50% Pre-Market: Why It Happened
07:12am, Thursday, 11'th Mar 2021
The stock price of Vir Biotechnology Inc (NASDAQ: VIR) has increased by over 50% pre-market. This is why it happened.
Vir/GSK's COVID-19 Antibody Therapy Cuts Hospitalization, Deaths by 85%, Seeks FDA Emergency Use Nod
05:13am, Thursday, 11'th Mar 2021
An Independent Data Monitoring Committee (IDMC) has recommended that the Phase 3 COMET-ICE trial, evaluating VIR-7831 (GSK4182136) as monotherapy for COVID-19, stop enrollment due to evidence of pro
Vir Biotechnology and GSK Announce VIR-7831 Reduces Hospitalization and Risk of Death in Early Treatment of Adults with COVID-19
08:22pm, Wednesday, 10'th Mar 2021
– Independent Data Monitoring Committee recommends stopping Phase 3 COMET-ICE trial early given an 85% reduction in hospitalization or death –
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vir Biotechnology, Inc. - VIR
08:55pm, Sunday, 07'th Mar 2021
New York, New York--(Newsfile Corp. - March 7, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Vir Biotechnology, Inc. ("Vir" or the "Company") (NASDAQ: VIR). Such investors ar
After 2 Licensing Deals Will GlaxoSmithKline Acquire Vir?
09:00am, Saturday, 06'th Mar 2021
The relationship could result in a marriage down the line.
Why Vir Biotechnology Stock Is Falling Today
12:52pm, Thursday, 04'th Mar 2021
Bearish commentary from an analyst may be to blame.
Are Options Traders Betting on a Big Move in Vir Biotechnology (VIR) Stock?
09:08am, Thursday, 04'th Mar 2021
Investors need to pay close attention to Vir Biotechnology (VIR) stock based on the movements in the options market lately.
VIR Stock: Why Vir Biotechnology Is Plunging Today
02:58pm, Wednesday, 03'rd Mar 2021
VIR stock is plunging on some pretty unfavorable news about a trial being suspended for the company's prospective Covid-19 vaccine. The post VIR Stock: Why Vir Biotechnology Is Plunging Today appeared
Vir Shares Plummeted Today. What to Know.
02:57pm, Wednesday, 03'rd Mar 2021
The company announced that a data and safety monitoring board had recommended ending a trial of its experimental antibody therapy in hospitalized Covid-19 patients.
Why Vir Biotechnology Stock Is Dropping Today
12:55pm, Wednesday, 03'rd Mar 2021
The company provided a discouraging regulatory update.
Coronavirus Mutations: Why The Battle Against Covid Is Just Beginning
07:00am, Friday, 26'th Feb 2021
The battle against Covid-19 is about to get uglier. Coronavirus mutations threaten to undercut a year's worth of work upholding Covid stocks like Pfizer, Moderna and Regeneron Pharmaceuticals.
Glaxo (GSK)/Vir Biotech to Develop Antibodies for Influenza
10:36am, Thursday, 18'th Feb 2021
Glaxo (GSK)/Vir Biotech expands their existing coronavirus collaboration for developing new monoclonal antibody candidates for influenza and other respiratory viruses.
Vir Biotechnology and GlaxoSmithKline Expand Their Partnership
02:20pm, Wednesday, 17'th Feb 2021
The biotech will get $345 million through an upfront payment and equity investment.
Why Vir Biotechnology Stock Is Higher Today
01:00pm, Wednesday, 17'th Feb 2021
The biotech is expanding its collaboration with a big partner.
Vir, GSK ink new R&D deal
08:10am, Wednesday, 17'th Feb 2021
Shares of Vir Biotechnology Inc. were up 12.8% in premarket trading on Wednesday after the company said it would expand its research agreement with GlaxoSmithKline to include the flu and other respira
